CompuMed regains OsteoGram rights
Bone densitometry firm CompuMed's big plans for its OsteoGram bone mineral density testing technology may have hit a snag with the announcement that it has reacquired exclusive worldwide rights from the Bone Measurement Institute (BMI), a non-profit
Bone densitometry firm CompuMed's big plans for its OsteoGram bone mineral density testing technology may have hit a snag with the announcement that it has reacquired exclusive worldwide rights from the Bone Measurement Institute (BMI), a non-profit Merck subsidiary that had licensed the technology in 1995 (SCAN 9/13/95). Manhattan Beach, CA-based CompuMed reported that the OsteoGram Analysis Center generated a disappointingly small stream of royalty income.
BMI will return the rights to the OsteoGram technology at no cost to CompuMed, and will discontinue operating the OsteoGram Analysis Center on February 28, according to CompuMed. The company is considering distribution options such as new licensing revenues, as well as worldwide marketing of OsteoGram.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
